Genenta Science S.p.A. Unsponsored ADR GNTA
0.69
0.02
2.99%
as of 25 Sep
- Market cap
- $32.4M
- P/E
- —
Follow GNTA
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
|
+7 more TTM periods Free account |
0.00% | 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(30.48) | (29.40) | (27.39) | (23.02) | |
Capital Expenditures |
(0.06) | (0.04) | (0.03) | (0.02) | |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(83.78%) | (107.86%) | (64.54%) | (35.30%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.67 | 0.92 | 3.21 | 0.71 | |
Capex/Depreciation |
(0.59) | (0.25) | (0.23) | (0.20) | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates